D. Tryfonopoulos

发表

Genetic evaluation based on family history and Her2 status correctly identifies TP53 mutations in very early onset breast cancer cases

D. Mavroudis, F. Fostira, D. Yannoukakos, 2015, Clinical genetics.

Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.

J. McHugh, S. Connolly, D. Fennelly, 2012, European journal of cancer care.

Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer

M. Karamouzis, A. Papavassiliou, S. Theocharis, 2019, Journal of Cancer Research and Clinical Oncology.

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

I. Boukovinas, G. Aravantinos, A. Psyrri, 2020, ESMO Open.

First-line chemotherapy with fluorouracil-epirubicin-navelbine (FEN) combination in advanced breast cancer.

M. Karamouzis, A. Ardavanis, D. Tryfonopoulos, 2005, Anticancer research.

Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.

F. Fostira, D. Yannoukakos, C. Papadimitriou, 2019, Clinical breast cancer.

Chemotherapy-associated recurrent pneumothoraces in lymphangioleiomyomatosis.

T. McDonnell, M. Keane, S. Sukor, 2010, Respiratory care.

Association of dehydroepiandrosterone-sulfate with endothelial function in young women with polycystic ovary syndrome.

J. Lekakis, A. Protogerou, C. Papamichael, 2006, European journal of endocrinology.

Acute Administration of Vitamin C Prolongs the Duration of Forearm Reactive Hyperemia in Patients with Hypercholesterolemia

J. Lekakis, A. Protogerou, T. Papaioannou, 2002 .

Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer.

M. Karamouzis, A. Ardavanis, D. Tryfonopoulos, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

A case of paraneoplastic autoimmune pancreatitis: mini-review of paraneoplastic syndromes in breast cancer.

L. Lekakis, G. Koumakis, D. Tryfonopoulos, 2012, Anticancer research.

Activity of dasatinib with chemotherapy in triple-negative breast cancer cells.

M. Clynes, J. Crown, N. O'Donovan, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial

E. McDermott, J. Crown, J. McCaffrey, 2019, Therapeutic advances in medical oncology.

Salvage chemotherapy with cisplatin and 5-fluorouracil in metastatic breast cancer. Particular activity against liver metastases.

L. Lekakis, G. Koumakis, D. Tryfonopoulos, 2012, Anticancer research.

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis

L. O’Driscoll, M. Clynes, J. Crown, 2010, British Journal of Cancer.

Prospects for non-immunological molecular therapeutics in melanoma.

A. Eustace, N. O'Donovan, D. Tryfonopoulos, 2010, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Src: a potential target for the treatment of triple-negative breast cancer.

E. McDermott, C. Quinn, J. Crown, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Aromatase Inhibitor-Associated Tendinopathy and Muscle Tendon Rupture: Report of Three Cases of This Exceedingly Rare Adverse Event

G. Koumakis, D. Tryfonopoulos, A. Grivas, 2018, Case Reports in Oncology.

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

F. Fostira, D. Yannoukakos, D. Mauri, 2018, Breast Cancer Research and Treatment.

One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene

F. Fostira, D. Yannoukakos, C. Papadimitriou, 2019, Journal of Medical Genetics.

Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial

M. Dimopoulos, G. Lazaridis, A. Psyrri, 2020, British Journal of Cancer.

Novel targeted agents in Her-2 positive and triple negative breast cancer

D. Tryfonopoulos, 2013 .

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study

A. Ardavanis, D. Tryfonopoulos, A. Alexopoulos, 2005, British Journal of Cancer.

Arterial stiffness in Type 1 diabetes mellitus is aggravated by autoimmune thyroid disease

M Alevizaki, J. Lekakis, A. Protogerou, 2005, Journal of endocrinological investigation.

AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study

G. Aravantinos, C. Petraki, A. Psyrri, 2021, Acta oncologica.

Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.

A. Scorilas, N. Arnogiannaki, A. Ardavanis, 2006, The oncologist.

Mucinous breast carcinoma with tall columnar cells.

G. Nakos, M. Galanopoulos, M. Tolia, 2018, Annals of the Royal College of Surgeons of England.

Mucinous breast carcinoma with tall columnar cells carcinoma – Mucinous breast carcinoma – Mucinous cystadenocarcinoma – Tall columnar cells CASE

G. Nakos, M. Tolia, G. Koumakis, 2018 .

A collecting duct carcinoma producing carcinoembryonic antigen and Ca-125 in a 29-year-old woman

M. Tolia, G. Koumakis, N. Tsoukalas, 2014, International Urology and Nephrology.

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the “one thousand HER2 patients” project

J. Geraghty, E. McDermott, C. Quinn, 2018, British Journal of Cancer.

Nivolumab-induced lichenoid granulomatous stomatitis in a patient with advanced melanoma: A case report

E. Georgakopoulou, D. Tryfonopoulos, I. Gkouveris, 2022, Molecular and clinical oncology.

Non-allergic nature of docetaxel-induced acute hypersensitivity reactions

A. Ardavanis, D. Tryfonopoulos, N. Baziotis, 2004, Anti-cancer drugs.

Coexistence of intracranial germ cell tumor and craniopharyngioma in an adolescent: case report and review of the literature.

M. Tolia, N. Goutas, G. Koumakis, 2013, International journal of clinical and experimental medicine.

Antibody–cytotoxic drug conjugates in clinical trials and future perspectives: the development of Trojan horses

D. Tryfonopoulos, 2014, memo - Magazine of European Medical Oncology.

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

F. Fostira, D. Yannoukakos, D. Mauri, 2018, Breast Cancer Research and Treatment.

Safety and Efficacy of Trastuzumab Every 3 Weeks Combined with Cytotoxic Chemotherapy in Patients with HER2-Positive Recurrent Breast Cancer: Findings from a Case Series

A. Scorilas, M. Karamouzis, A. Ardavanis, 2005, Oncology Research and Treatment.